Professor Charlotte Teunissen aims at developing biomarkers for neurodegenerative diseases.
Her vision is to improve biological diagnosis, therapy development and monitoring of disease progression through biomarkers in body fluids, such as cerebrospinal fluid and blood.
Her strategy is to address the whole workflow from identification of candidate biomarkers, assay development and finally clinical implementation, and collaborate with all relevant stakeholders in this process. Hereby, she envisions to find better solutions to address important unmet medical needs and increase our understanding of neurodegenerative and neuroinflammatory diseases.
Her current major disease topics are dementias, such as Alzheimer’s disease, and Multiple Sclerosis.